IRCT20221108056446N2
Recruiting
Phase 3
Investigating the effectiveness of dalfampridine in improving spasticity in patients with severe brain trauma
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Severe traumatic brain injury.
- Sponsor
- Esfahan University of Medical Sciences
- Enrollment
- 80
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Being between 18 and 65 years old
- •More than a month has passed since the beginning of the trauma
- •Having a level of consciousness less than 9
- •Not having a neurological or psychological disease before the trauma
- •Presence of spasticity in the upper or lower limbs according to the Ashworth criteria
Exclusion Criteria
- •Lack of consent of the patient's companion to enter the study
- •Having a level of consciousness higher than 9 at the beginning of the trauma
- •History of seizures, kidney and liver diseases
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Effect of Dalfampridine in Treatment of Spinal Cord InjuryThoracic Spinal Cord Injury.Injury of spinal cord, level unspecifiedT09.3IRCT20231019059767N1Mashhad University of Medical Sciences52
Not yet recruiting
Phase 3
Efficacy of Dalfyra (extended release Fampridine) in fatigue in multiple sclerosis patientsFatigue in patients with multiple sclerosis.Multiple sclerosisIRCT20210429051129N1Qazvin University of Medical Sciences88
Completed
Phase 3
Study of Fampridine-ER Tablets in Patients With Multiple SclerosisMultiple SclerosisNCT01328379Acorda Therapeutics430
Recruiting
Phase 3
The effect of Dalfampridine in HTLV-1 patientsHTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients.Tropical spastic paraplegiaG04.1IRCT20180618040127N4Mashhad University of Medical Sciences40
Recruiting
Phase 3
The effect of famotidine on reducing the side effects of prostate cancer radiotherapyIRCT20231121060132N1Kermanshah University of Medical Sciences50